Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Article

Tong, XW, Engehausen, DG, Kaufman, RH et al. (1998). Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy . ANTICANCER RESEARCH, 18(2A), 713-718.

cited authors

  • Tong, XW; Engehausen, DG; Kaufman, RH; Agoulnik, I; Contant, C; Freund, CTF; Oehler, MK; Kim, TE; Hasenburg, A; Woo, SLC; Kieback, DG

sustainable development goals

authors

publication date

  • March 1, 1998

published in

keywords

  • 9-(2-HYDROXYETHOXYMETHYL)GUANINE
  • ADV/RSV-TK
  • BRAIN-TUMORS
  • COLORIMETRIC ASSAY
  • DNA-POLYMERASE
  • IN-VIVO
  • Life Sciences & Biomedicine
  • Oncology
  • PHOSPHORYLATION
  • REGRESSION
  • Science & Technology
  • TRANSDUCTION
  • TRIPHOSPHATE
  • VIRUS-INFECTED CELLS
  • acyclovir
  • cell killing
  • ganciclovir
  • toxicity

publisher

  • INT INST ANTICANCER RESEARCH

start page

  • 713

end page

  • 718

volume

  • 18

issue

  • 2A